{"id":35090,"date":"2025-06-24T00:46:29","date_gmt":"2025-06-24T04:46:29","guid":{"rendered":"https:\/\/joinastudy.ca\/lutilisation-dozempic-et-de-medicaments-similaires-a-triple-chez-les-non-diabetiques-selon-une-etude\/"},"modified":"2025-06-24T00:49:01","modified_gmt":"2025-06-24T04:49:01","slug":"lutilisation-dozempic-et-de-medicaments-similaires-a-triple-chez-les-non-diabetiques-selon-une-etude","status":"publish","type":"post","link":"https:\/\/joinastudy.ca\/fr\/lutilisation-dozempic-et-de-medicaments-similaires-a-triple-chez-les-non-diabetiques-selon-une-etude\/","title":{"rendered":"L\u2019utilisation d\u2019Ozempic et de m\u00e9dicaments similaires a tripl\u00e9 chez les non-diab\u00e9tiques, selon une \u00e9tude"},"content":{"rendered":"

De plus en plus d\u2019Am\u00e9ricains se tournent vers des m\u00e9dicaments contre le diab\u00e8te comme Ozempic, non pas pour traiter le diab\u00e8te, mais pour perdre du poids. Une nouvelle \u00e9tude r\u00e9v\u00e8le que l\u2019utilisation des m\u00e9dicaments GLP-1 par des adultes am\u00e9ricains sans diab\u00e8te a plus que tripl\u00e9 entre 2018 et 2022. Durant cette p\u00e9riode, les d\u00e9penses annuelles pour ces m\u00e9dicaments sont pass\u00e9es de 1,6\u202fmilliard \u00e0 5,8\u202fmilliards de dollars.<\/strong><\/p>\n

Les m\u00e9dicaments GLP-1, tels qu\u2019Ozempic et Mounjaro, ont \u00e9t\u00e9 initialement d\u00e9velopp\u00e9s pour traiter le diab\u00e8te de type 2. Ils imitent une hormone naturelle qui aide \u00e0 contr\u00f4ler la glyc\u00e9mie et \u00e0 r\u00e9duire l\u2019app\u00e9tit. Les versions plus r\u00e9centes, comme Wegovy et Zepbound, ne n\u00e9cessitent qu\u2019une injection hebdomadaire et sont d\u00e9sormais \u00e9galement approuv\u00e9es pour traiter l\u2019ob\u00e9sit\u00e9.<\/p>\n

En 2022, environ 854\u202f000 adultes sans diab\u00e8te avaient rempli au moins une ordonnance pour un m\u00e9dicament GLP-1. Ce groupe repr\u00e9sentait 0,4\u202f% des adultes am\u00e9ricains, contre seulement 0,1\u202f% en 2018. La majorit\u00e9 des utilisateurs sans diab\u00e8te \u00e9taient des femmes (64\u202f%), des personnes blanches (73\u202f%) et pr\u00e9sentaient un IMC moyen de 35,7 \u2014 ce qui correspond \u00e0 une cat\u00e9gorie d\u2019ob\u00e9sit\u00e9.<\/p>\n

Des sondages sugg\u00e8rent que le nombre r\u00e9el d\u2019utilisateurs est probablement encore plus \u00e9lev\u00e9 aujourd\u2019hui. Un sondage r\u00e9alis\u00e9 en mai 2024 a r\u00e9v\u00e9l\u00e9 que 12\u202f% des adultes am\u00e9ricains avaient d\u00e9clar\u00e9 avoir pris un m\u00e9dicament GLP-1 et qu\u2019environ un tiers de la population en avait beaucoup entendu parler.<\/p>\n

La popularit\u00e9 des GLP-1 a entra\u00een\u00e9 des profits consid\u00e9rables pour les fabricants. Novo Nordisk, le fabricant d\u2019Ozempic et de Wegovy, a vu son chiffre d\u2019affaires grimper \u00e0 40,5\u202fmilliards de dollars en 2024. Eli Lilly, qui fabrique Mounjaro et Zepbound, a quant \u00e0 lui engrang\u00e9 45\u202fmilliards cette m\u00eame ann\u00e9e.<\/p>\n

\u00c0 mesure que de plus en plus de personnes ont recours \u00e0 ces m\u00e9dicaments pour perdre du poids, des questions subsistent quant \u00e0 leurs effets \u00e0 long terme et \u00e0 leur accessibilit\u00e9 \u2014 mais une chose est certaine\u202f: la demande explose.<\/p>\n

Pour en savoir plus sur ce sujet, cliquez ici.<\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"

De plus en plus d\u2019Am\u00e9ricains se tournent vers des m\u00e9dicaments contre le diab\u00e8te comme Ozempic, non pas pour traiter le diab\u00e8te, mais pour perdre du poids. Une nouvelle \u00e9tude r\u00e9v\u00e8le que l\u2019utilisation des m\u00e9dicaments GLP-1 par des adultes am\u00e9ricains sans diab\u00e8te a plus que tripl\u00e9 entre 2018 et 2022. Durant cette p\u00e9riode, les d\u00e9penses annuelles<\/p>\n","protected":false},"author":964,"featured_media":34625,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[780,781,772,775],"tags":[],"class_list":["post-35090","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-obesite-et-perte-de-poids","category-diabete","category-sante-et-bien-etre","category-nouvelles-de-lindustrie","category-780","category-781","category-772","category-775","description-off"],"acf":[],"yoast_head":"\nL\u2019utilisation d\u2019Ozempic et de m\u00e9dicaments similaires a tripl\u00e9 chez les non-diab\u00e9tiques<\/title>\n<meta name=\"description\" content=\"Une nouvelle \u00e9tude r\u00e9v\u00e8le que l\u2019utilisation des m\u00e9dicaments GLP-1 chez les adultes am\u00e9ricains sans diab\u00e8te a plus que tripl\u00e9 entre 2018 et 2022.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/joinastudy.ca\/fr\/lutilisation-dozempic-et-de-medicaments-similaires-a-triple-chez-les-non-diabetiques-selon-une-etude\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"L\u2019utilisation d\u2019Ozempic et de m\u00e9dicaments similaires a tripl\u00e9 chez les non-diab\u00e9tiques, selon une \u00e9tude\" \/>\n<meta property=\"og:description\" content=\"Une nouvelle \u00e9tude r\u00e9v\u00e8le que l\u2019utilisation des m\u00e9dicaments GLP-1 chez les adultes am\u00e9ricains sans diab\u00e8te a plus que tripl\u00e9 entre 2018 et 2022.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/joinastudy.ca\/fr\/lutilisation-dozempic-et-de-medicaments-similaires-a-triple-chez-les-non-diabetiques-selon-une-etude\/\" \/>\n<meta property=\"og:site_name\" content=\"JoinAStudy.ca\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/joinastudy.ca\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-24T04:46:29+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-24T04:49:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/joinastudy.ca\/wp-content\/uploads\/Weight-loss-Programs-for-Overweight.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"667\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"JoinAStudy Team\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@JoinAStudy_ca\" \/>\n<meta name=\"twitter:site\" content=\"@JoinAStudy_ca\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"JoinAStudy Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/lutilisation-dozempic-et-de-medicaments-similaires-a-triple-chez-les-non-diabetiques-selon-une-etude\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/lutilisation-dozempic-et-de-medicaments-similaires-a-triple-chez-les-non-diabetiques-selon-une-etude\\\/\"},\"author\":{\"name\":\"JoinAStudy Team\",\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/#\\\/schema\\\/person\\\/da824a10716e724d72676ec94d865d71\"},\"headline\":\"L\u2019utilisation d\u2019Ozempic et de m\u00e9dicaments similaires a tripl\u00e9 chez les non-diab\u00e9tiques, selon une \u00e9tude\",\"datePublished\":\"2025-06-24T04:46:29+00:00\",\"dateModified\":\"2025-06-24T04:49:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/lutilisation-dozempic-et-de-medicaments-similaires-a-triple-chez-les-non-diabetiques-selon-une-etude\\\/\"},\"wordCount\":372,\"publisher\":{\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/lutilisation-dozempic-et-de-medicaments-similaires-a-triple-chez-les-non-diabetiques-selon-une-etude\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/joinastudy.ca\\\/wp-content\\\/uploads\\\/Weight-loss-Programs-for-Overweight.jpg\",\"articleSection\":[\"Ob\u00e9sit\u00e9 et perte de poids\",\"Diab\u00e8te\",\"Sant\u00e9 et bien-\u00eatre\",\"Nouvelles de l\u2019industrie\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/lutilisation-dozempic-et-de-medicaments-similaires-a-triple-chez-les-non-diabetiques-selon-une-etude\\\/\",\"url\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/lutilisation-dozempic-et-de-medicaments-similaires-a-triple-chez-les-non-diabetiques-selon-une-etude\\\/\",\"name\":\"L\u2019utilisation d\u2019Ozempic et de m\u00e9dicaments similaires a tripl\u00e9 chez les non-diab\u00e9tiques\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/lutilisation-dozempic-et-de-medicaments-similaires-a-triple-chez-les-non-diabetiques-selon-une-etude\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/lutilisation-dozempic-et-de-medicaments-similaires-a-triple-chez-les-non-diabetiques-selon-une-etude\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/joinastudy.ca\\\/wp-content\\\/uploads\\\/Weight-loss-Programs-for-Overweight.jpg\",\"datePublished\":\"2025-06-24T04:46:29+00:00\",\"dateModified\":\"2025-06-24T04:49:01+00:00\",\"description\":\"Une nouvelle \u00e9tude r\u00e9v\u00e8le que l\u2019utilisation des m\u00e9dicaments GLP-1 chez les adultes am\u00e9ricains sans diab\u00e8te a plus que tripl\u00e9 entre 2018 et 2022.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/lutilisation-dozempic-et-de-medicaments-similaires-a-triple-chez-les-non-diabetiques-selon-une-etude\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/lutilisation-dozempic-et-de-medicaments-similaires-a-triple-chez-les-non-diabetiques-selon-une-etude\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/lutilisation-dozempic-et-de-medicaments-similaires-a-triple-chez-les-non-diabetiques-selon-une-etude\\\/#primaryimage\",\"url\":\"https:\\\/\\\/joinastudy.ca\\\/wp-content\\\/uploads\\\/Weight-loss-Programs-for-Overweight.jpg\",\"contentUrl\":\"https:\\\/\\\/joinastudy.ca\\\/wp-content\\\/uploads\\\/Weight-loss-Programs-for-Overweight.jpg\",\"width\":1000,\"height\":667,\"caption\":\"GLP-1 weight loss trend\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/lutilisation-dozempic-et-de-medicaments-similaires-a-triple-chez-les-non-diabetiques-selon-une-etude\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"L\u2019utilisation d\u2019Ozempic et de m\u00e9dicaments similaires a tripl\u00e9 chez les non-diab\u00e9tiques, selon une \u00e9tude\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/\",\"name\":\"JoinAStudy.ca\",\"description\":\"JoinAStudy.ca - Help create a healthier future\",\"publisher\":{\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/#organization\",\"name\":\"JoinAStudy.ca\",\"url\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/joinastudy.ca\\\/wp-content\\\/uploads\\\/JoinaStudy-Logo-Mobile-e1520526932796.png\",\"contentUrl\":\"https:\\\/\\\/joinastudy.ca\\\/wp-content\\\/uploads\\\/JoinaStudy-Logo-Mobile-e1520526932796.png\",\"width\":118,\"height\":65,\"caption\":\"JoinAStudy.ca\"},\"image\":{\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/joinastudy.ca\",\"https:\\\/\\\/x.com\\\/JoinAStudy_ca\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UC_ed0XmzH5ImSNOEJcdXKqg\"],\"publishingPrinciples\":\"https:\\\/\\\/joinastudy.ca\\\/why-join-a-study\\\/\",\"ownershipFundingInfo\":\"https:\\\/\\\/joinastudy.ca\\\/information-disclaimer\\\/\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/#\\\/schema\\\/person\\\/da824a10716e724d72676ec94d865d71\",\"name\":\"JoinAStudy Team\",\"url\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/author\\\/grant\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"L\u2019utilisation d\u2019Ozempic et de m\u00e9dicaments similaires a tripl\u00e9 chez les non-diab\u00e9tiques","description":"Une nouvelle \u00e9tude r\u00e9v\u00e8le que l\u2019utilisation des m\u00e9dicaments GLP-1 chez les adultes am\u00e9ricains sans diab\u00e8te a plus que tripl\u00e9 entre 2018 et 2022.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/joinastudy.ca\/fr\/lutilisation-dozempic-et-de-medicaments-similaires-a-triple-chez-les-non-diabetiques-selon-une-etude\/","og_locale":"fr_FR","og_type":"article","og_title":"L\u2019utilisation d\u2019Ozempic et de m\u00e9dicaments similaires a tripl\u00e9 chez les non-diab\u00e9tiques, selon une \u00e9tude","og_description":"Une nouvelle \u00e9tude r\u00e9v\u00e8le que l\u2019utilisation des m\u00e9dicaments GLP-1 chez les adultes am\u00e9ricains sans diab\u00e8te a plus que tripl\u00e9 entre 2018 et 2022.","og_url":"https:\/\/joinastudy.ca\/fr\/lutilisation-dozempic-et-de-medicaments-similaires-a-triple-chez-les-non-diabetiques-selon-une-etude\/","og_site_name":"JoinAStudy.ca","article_publisher":"https:\/\/www.facebook.com\/joinastudy.ca","article_published_time":"2025-06-24T04:46:29+00:00","article_modified_time":"2025-06-24T04:49:01+00:00","og_image":[{"width":1000,"height":667,"url":"https:\/\/joinastudy.ca\/wp-content\/uploads\/Weight-loss-Programs-for-Overweight.jpg","type":"image\/jpeg"}],"author":"JoinAStudy Team","twitter_card":"summary_large_image","twitter_creator":"@JoinAStudy_ca","twitter_site":"@JoinAStudy_ca","twitter_misc":{"\u00c9crit par":"JoinAStudy Team","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/joinastudy.ca\/fr\/lutilisation-dozempic-et-de-medicaments-similaires-a-triple-chez-les-non-diabetiques-selon-une-etude\/#article","isPartOf":{"@id":"https:\/\/joinastudy.ca\/fr\/lutilisation-dozempic-et-de-medicaments-similaires-a-triple-chez-les-non-diabetiques-selon-une-etude\/"},"author":{"name":"JoinAStudy Team","@id":"https:\/\/joinastudy.ca\/fr\/#\/schema\/person\/da824a10716e724d72676ec94d865d71"},"headline":"L\u2019utilisation d\u2019Ozempic et de m\u00e9dicaments similaires a tripl\u00e9 chez les non-diab\u00e9tiques, selon une \u00e9tude","datePublished":"2025-06-24T04:46:29+00:00","dateModified":"2025-06-24T04:49:01+00:00","mainEntityOfPage":{"@id":"https:\/\/joinastudy.ca\/fr\/lutilisation-dozempic-et-de-medicaments-similaires-a-triple-chez-les-non-diabetiques-selon-une-etude\/"},"wordCount":372,"publisher":{"@id":"https:\/\/joinastudy.ca\/fr\/#organization"},"image":{"@id":"https:\/\/joinastudy.ca\/fr\/lutilisation-dozempic-et-de-medicaments-similaires-a-triple-chez-les-non-diabetiques-selon-une-etude\/#primaryimage"},"thumbnailUrl":"https:\/\/joinastudy.ca\/wp-content\/uploads\/Weight-loss-Programs-for-Overweight.jpg","articleSection":["Ob\u00e9sit\u00e9 et perte de poids","Diab\u00e8te","Sant\u00e9 et bien-\u00eatre","Nouvelles de l\u2019industrie"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/joinastudy.ca\/fr\/lutilisation-dozempic-et-de-medicaments-similaires-a-triple-chez-les-non-diabetiques-selon-une-etude\/","url":"https:\/\/joinastudy.ca\/fr\/lutilisation-dozempic-et-de-medicaments-similaires-a-triple-chez-les-non-diabetiques-selon-une-etude\/","name":"L\u2019utilisation d\u2019Ozempic et de m\u00e9dicaments similaires a tripl\u00e9 chez les non-diab\u00e9tiques","isPartOf":{"@id":"https:\/\/joinastudy.ca\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/joinastudy.ca\/fr\/lutilisation-dozempic-et-de-medicaments-similaires-a-triple-chez-les-non-diabetiques-selon-une-etude\/#primaryimage"},"image":{"@id":"https:\/\/joinastudy.ca\/fr\/lutilisation-dozempic-et-de-medicaments-similaires-a-triple-chez-les-non-diabetiques-selon-une-etude\/#primaryimage"},"thumbnailUrl":"https:\/\/joinastudy.ca\/wp-content\/uploads\/Weight-loss-Programs-for-Overweight.jpg","datePublished":"2025-06-24T04:46:29+00:00","dateModified":"2025-06-24T04:49:01+00:00","description":"Une nouvelle \u00e9tude r\u00e9v\u00e8le que l\u2019utilisation des m\u00e9dicaments GLP-1 chez les adultes am\u00e9ricains sans diab\u00e8te a plus que tripl\u00e9 entre 2018 et 2022.","breadcrumb":{"@id":"https:\/\/joinastudy.ca\/fr\/lutilisation-dozempic-et-de-medicaments-similaires-a-triple-chez-les-non-diabetiques-selon-une-etude\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/joinastudy.ca\/fr\/lutilisation-dozempic-et-de-medicaments-similaires-a-triple-chez-les-non-diabetiques-selon-une-etude\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/joinastudy.ca\/fr\/lutilisation-dozempic-et-de-medicaments-similaires-a-triple-chez-les-non-diabetiques-selon-une-etude\/#primaryimage","url":"https:\/\/joinastudy.ca\/wp-content\/uploads\/Weight-loss-Programs-for-Overweight.jpg","contentUrl":"https:\/\/joinastudy.ca\/wp-content\/uploads\/Weight-loss-Programs-for-Overweight.jpg","width":1000,"height":667,"caption":"GLP-1 weight loss trend"},{"@type":"BreadcrumbList","@id":"https:\/\/joinastudy.ca\/fr\/lutilisation-dozempic-et-de-medicaments-similaires-a-triple-chez-les-non-diabetiques-selon-une-etude\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/joinastudy.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"L\u2019utilisation d\u2019Ozempic et de m\u00e9dicaments similaires a tripl\u00e9 chez les non-diab\u00e9tiques, selon une \u00e9tude"}]},{"@type":"WebSite","@id":"https:\/\/joinastudy.ca\/fr\/#website","url":"https:\/\/joinastudy.ca\/fr\/","name":"JoinAStudy.ca","description":"JoinAStudy.ca - Help create a healthier future","publisher":{"@id":"https:\/\/joinastudy.ca\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/joinastudy.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/joinastudy.ca\/fr\/#organization","name":"JoinAStudy.ca","url":"https:\/\/joinastudy.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/joinastudy.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/joinastudy.ca\/wp-content\/uploads\/JoinaStudy-Logo-Mobile-e1520526932796.png","contentUrl":"https:\/\/joinastudy.ca\/wp-content\/uploads\/JoinaStudy-Logo-Mobile-e1520526932796.png","width":118,"height":65,"caption":"JoinAStudy.ca"},"image":{"@id":"https:\/\/joinastudy.ca\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/joinastudy.ca","https:\/\/x.com\/JoinAStudy_ca","https:\/\/www.youtube.com\/channel\/UC_ed0XmzH5ImSNOEJcdXKqg"],"publishingPrinciples":"https:\/\/joinastudy.ca\/why-join-a-study\/","ownershipFundingInfo":"https:\/\/joinastudy.ca\/information-disclaimer\/"},{"@type":"Person","@id":"https:\/\/joinastudy.ca\/fr\/#\/schema\/person\/da824a10716e724d72676ec94d865d71","name":"JoinAStudy Team","url":"https:\/\/joinastudy.ca\/fr\/author\/grant\/"}]}},"_links":{"self":[{"href":"https:\/\/joinastudy.ca\/fr\/wp-json\/wp\/v2\/posts\/35090","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/joinastudy.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/joinastudy.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/joinastudy.ca\/fr\/wp-json\/wp\/v2\/users\/964"}],"replies":[{"embeddable":true,"href":"https:\/\/joinastudy.ca\/fr\/wp-json\/wp\/v2\/comments?post=35090"}],"version-history":[{"count":0,"href":"https:\/\/joinastudy.ca\/fr\/wp-json\/wp\/v2\/posts\/35090\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/joinastudy.ca\/fr\/wp-json\/wp\/v2\/media\/34625"}],"wp:attachment":[{"href":"https:\/\/joinastudy.ca\/fr\/wp-json\/wp\/v2\/media?parent=35090"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/joinastudy.ca\/fr\/wp-json\/wp\/v2\/categories?post=35090"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/joinastudy.ca\/fr\/wp-json\/wp\/v2\/tags?post=35090"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}